ADD CONDITION

items per page

Bvibe Spearmint Deep Throat

Last content change checked dailysee data sync status

Active ingredient
Benzocaine 25 mg/1 mL
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2025
Label revision date
August 22, 2025
Active ingredient
Benzocaine 25 mg/1 mL
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2025
Label revision date
August 22, 2025
Manufacturer
COTR Inc
Registration number
M017
NDC root
85775-112

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

COTR is a medication designed to temporarily reduce the gag reflex by desensitizing the throat. This can be particularly helpful for individuals who may experience discomfort during certain oral activities. By calming the sensitivity in the throat, COTR allows for a more comfortable experience.

Uses

If you're looking for a way to make certain oral activities more comfortable, this medication can help. It temporarily reduces your gag reflex by desensitizing the throat, allowing for deeper oral engagement without the discomfort that can sometimes occur. This can be particularly useful in various situations where you want to enhance your experience.

Dosage and Administration

To use this medication, you will spray it directly into your throat. For adults aged 18 and older, you can use 1 to 2 sprays at a time, but make sure not to exceed 3 to 4 sprays in one session. After spraying, it's important to wait 30 to 60 seconds before swallowing to allow the medication to take effect. You should also wait 1 to 2 minutes for the full numbing effect, which will last for about an hour.

Remember, you can use a maximum of 4 sprays in one session and no more than 12 sprays within a 24-hour period. This helps ensure you get the relief you need while staying safe.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no known reasons you should avoid using it. However, always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

You should be aware of some important warnings and potential side effects when using this medication. If you are allergic to benzocaine or other local anesthetics like lidocaine or procaine, you should avoid using it. Additionally, if you have a history of methemoglobinemia (a condition where the blood cannot carry oxygen effectively) or are taking related medications such as nitrates or sulfonamides, do not use this product.

While using the medication, be careful to avoid contact with your eyes and nostrils; if contact occurs, rinse thoroughly. Seek immediate medical help if you experience excessive numbness, breathing difficulties, dizziness, or bluish skin. You should also stop using the product and consult a doctor if you notice severe burning, swelling, irritation, a rash, or prolonged numbness lasting more than 1-2 hours. Overusing the medication can increase the risk of methemoglobinemia, so avoid applying it continuously or in large amounts.

Warnings and Precautions

This product is for external use only, so please do not apply it to your genitals or other sensitive areas. If you are allergic to benzocaine or other local anesthetics like lidocaine or procaine, you should avoid using this product. Additionally, do not use it if you have a history of methemoglobinemia (a condition that affects the blood) or if you are taking related medications such as nitrates or sulfonamides. Be cautious not to apply it to irritated or broken skin, and avoid contact with your eyes and nostrils—rinse thoroughly if contact occurs.

While using this product, do not swallow it right away; allow it to numb your throat first. It’s important to avoid eating or drinking for at least one hour after use to prevent choking. Seek immediate medical help if you experience excessive numbness, breathing difficulties, dizziness, or bluish skin. You should stop using the product and consult your doctor if you notice severe burning, swelling, irritation, rash, or if numbness lasts longer than 1-2 hours. If you have respiratory, heart, or liver issues, are pregnant or breastfeeding, or are taking other medications, ask your doctor before use. Keep this product out of reach of children, and contact Poison Control at 1-800-222-1222 if it is swallowed. Overusing this product may increase the risk of methemoglobinemia, so avoid continuous or large applications.

Overdose

If you take too much of this medication, it can increase the risk of a condition called methemoglobinemia, which affects the blood's ability to carry oxygen. If you suspect an overdose, it's important to act quickly. You should contact Poison Control at 1-800-222-1222 for guidance on what to do next.

If you experience symptoms such as unusual shortness of breath, a bluish color to your skin or lips, or any other concerning signs, seek immediate medical help. Your health and safety are the top priority, so don’t hesitate to reach out for assistance.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult your doctor before using this medication. Additionally, you should reach out to your healthcare provider if you have any respiratory, heart, or liver issues, or if you are taking other medications that might interact with this one. Your health and the health of your baby are the top priority, so getting professional advice is essential.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to consult your doctor before using any new medications, especially if you have respiratory, heart, or liver issues. Your healthcare provider can help you understand any potential risks and ensure that the medication is safe for you and your baby. Always keep them informed about any other medications you are taking, as some can interact with new treatments. Taking these precautions can help protect your health and your baby's well-being.

Pediatric Use

It's important to keep this medication out of reach of children. If a child accidentally swallows it, contact Poison Control at 1-800-222-1222 right away. You should not use this medication if your child has a history of methemoglobinemia (a condition that affects blood oxygen levels) or is taking certain medications like nitrates or sulfonamides.

When using the medication, be careful to avoid contact with the eyes and nostrils; if contact happens, rinse thoroughly. After application, do not let your child swallow immediately to allow for throat numbing, and avoid eating or drinking for at least one hour to prevent choking. If you notice excessive numbness, breathing difficulties, dizziness, or a bluish tint to the skin, seek medical help immediately. Additionally, stop using the medication and consult a doctor if your child experiences severe burning, swelling, irritation, rash, or prolonged numbness lasting more than 1-2 hours. Always ask a doctor before use if your child has respiratory, heart, or liver issues, is pregnant or breastfeeding, or is taking other medications that might interact.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that healthcare providers may not have tailored guidelines for elderly patients.

If you or a loved one is an older adult considering this medication, it’s important to discuss any potential risks and benefits with your healthcare provider. They can help determine the best approach based on individual health needs and circumstances.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to consult your doctor before using this medication. Your healthcare provider can help determine if it's safe for you, especially if you have other health issues like respiratory or heart conditions, are pregnant or breastfeeding, or are taking other medications that might interact with it.

Always prioritize your health by discussing any concerns with your doctor to ensure the best care tailored to your needs.

Drug Interactions

It's important to be aware of certain interactions when considering this medication. If you are allergic to benzocaine or other local anesthetics, such as lidocaine or procaine, you should avoid using this product. Additionally, if you have a history of methemoglobinemia (a condition that affects the blood's ability to carry oxygen) or are taking related medications like nitrates or sulfonamides, you should not use this medication.

Before starting this treatment, make sure to discuss any other medications you are currently taking with your healthcare provider. This is crucial to ensure that there are no potential interactions that could affect your health. Always prioritize open communication with your doctor to keep your treatment safe and effective.

Storage and Handling

You can feel confident that there are no specific storage or handling instructions for this product or device. This means you can store it in a standard environment without any special requirements. Always ensure that you handle it with care to maintain its integrity and safety. If you have any questions about its use or safety, don’t hesitate to reach out for more information.

Additional Information

You should use this medication by spraying 1-2 times into your throat, with a maximum of 3-4 sprays per use. After spraying, wait 30-60 seconds before swallowing to allow the medication to take effect, which may take 1-2 minutes. The numbing sensation will last for about an hour, and you should not exceed 4 sprays in a single session or 12 sprays in a 24-hour period.

It's important to keep this medication out of reach of children. If a child accidentally swallows it, contact Poison Control immediately for assistance.

FAQ

What is COTR used for?

COTR temporarily reduces the gag reflex by desensitizing the throat for deeper oral activity.

How should I use COTR?

For adults (18+), spray 1-2 times to the throat, with a maximum of 3-4 sprays per use. Wait 30-60 seconds before swallowing.

What are the dosage limits for COTR?

You can use a maximum of 4 sprays per session and 12 sprays within 24 hours.

Are there any allergies I should be aware of?

Avoid COTR if you are allergic to benzocaine or other local anesthetics like lidocaine or procaine.

Who should not use COTR?

Do not use COTR if you have a history of methemoglobinemia or are taking related medications such as nitrates or sulfonamides.

What should I do if I experience side effects?

Seek immediate medical help for excessive numbness, breathing issues, dizziness, or bluish skin. Stop use and consult a doctor if you experience severe burning, swelling, irritation, rash, or prolonged numbing.

Can I eat or drink after using COTR?

Avoid eating or drinking for 1 hour after use to prevent choking.

What should I do if COTR is swallowed?

Keep COTR out of reach of children and contact Poison Control at 1-800-222-1222 if swallowed.

Is there any specific information for elderly patients?

No specific information regarding geriatric use or dosage adjustments is provided.

Should I consult a doctor before using COTR?

Yes, ask a doctor before use if you have respiratory, heart, or liver issues, are pregnant or breastfeeding, or take interacting medications.

Packaging Info

Below are the non-prescription pack sizes of Bvibe Spearmint Deep Throat (benzocaine numbing spray). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bvibe Spearmint Deep Throat.
Details

Drug Information (PDF)

This file contains official product information for Bvibe Spearmint Deep Throat, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Uses and Indications

This drug is indicated for the temporary reduction of the gag reflex by desensitizing the throat, facilitating deeper oral activity. It is intended for use in situations where such desensitization is clinically necessary.

Dosage and Administration

For adults aged 18 years and older, the recommended dosage is 1 to 2 sprays administered to the throat, with a maximum of 3 to 4 sprays per use. It is advised to allow 30 to 60 seconds before swallowing to ensure optimal absorption, and a waiting period of 1 to 2 minutes is recommended for the full effect to be realized. The numbing sensation typically fades within one hour.

The administration should be performed via the throat using the spray method. The maximum allowable dosage is 4 sprays per session, not to exceed 12 sprays within a 24-hour period.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only; this product should not be applied to the genitals or other sensitive body areas.

Allergy Alert Individuals with a known allergy to benzocaine or other local anesthetics, such as lidocaine or procaine, should avoid using this product.

Contraindications This product is contraindicated in patients with a history of methemoglobinemia or those who are taking related medications, including nitrates and sulfonamides. It should not be applied to irritated or broken mucous membranes.

Precautions During Use Care should be taken to avoid contact with the eyes and nostrils; in the event of contact, the area should be rinsed thoroughly. Users should refrain from swallowing the product immediately to allow for effective throat numbing. To minimize the risk of choking, it is advised to avoid eating or drinking for at least one hour following use.

Adverse Reactions Seek immediate medical attention if symptoms such as excessive numbness, breathing difficulties, dizziness, or bluish skin occur. Users should discontinue use and consult a healthcare professional if they experience severe burning, swelling, irritation, rash, or prolonged numbness lasting more than 1-2 hours.

Consultation Recommendations Prior to use, individuals with respiratory, heart, or liver conditions, as well as those who are pregnant, breastfeeding, or taking medications that may interact with this product, should consult a healthcare provider.

Pediatric Safety This product should be kept out of reach of children. In the event of accidental ingestion, contact Poison Control at 1-800-222-1222.

Risk of Overuse Caution is advised regarding the overuse of this product, as it may increase the risk of methemoglobinemia. Continuous or large-scale use should be avoided to mitigate this risk.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this product. Serious adverse reactions include severe allergic reactions, particularly in individuals with a known allergy to benzocaine or other local anesthetics such as lidocaine and procaine. Patients with a history of methemoglobinemia or those taking related medications, including nitrates and sulfonamides, should avoid using this product due to the risk of exacerbating their condition.

In clinical settings, patients have reported symptoms requiring immediate medical attention, including excessive numbness, breathing difficulties, dizziness, and bluish skin. These symptoms necessitate prompt evaluation and intervention. Additionally, patients are advised to discontinue use and consult a healthcare professional if they experience severe burning, swelling, irritation, rash, or prolonged numbness lasting more than 1 to 2 hours.

It is important to note that overuse of this product may increase the risk of methemoglobinemia. Patients should avoid continuous or large applications to mitigate this risk. Care should also be taken to prevent contact with the eyes and nostrils; if such contact occurs, rinsing is recommended.

Drug Interactions

Patients should be aware of specific drug interactions associated with this medication, particularly concerning allergies and pre-existing conditions.

Allergic Reactions This medication should be avoided in individuals with a known allergy to benzocaine or other local anesthetics, such as lidocaine or procaine.

Methemoglobinemia The use of this medication is contraindicated in patients with a history of methemoglobinemia. Additionally, caution is advised for those who are taking related medications, including nitrates and sulfonamides, as these may exacerbate the condition.

Consultation Prior to Use Patients are encouraged to consult a healthcare professional before using this medication if they are currently taking any interacting medications. This is essential to ensure safety and efficacy in the context of their overall treatment plan.

Packaging & NDC

Below are the non-prescription pack sizes of Bvibe Spearmint Deep Throat (benzocaine numbing spray). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bvibe Spearmint Deep Throat.
Details

Pediatric Use

Pediatric patients should be closely monitored when using this medication. It is essential to keep the product out of reach of children, and in the event of accidental ingestion, contact Poison Control at 1-800-222-1222 immediately.

This medication is contraindicated in individuals with a history of methemoglobinemia or those taking related medications, such as nitrates or sulfonamides. Pediatric patients should avoid contact with the eyes and nostrils; if contact occurs, the area should be rinsed thoroughly.

Patients should refrain from swallowing the medication immediately to allow for throat numbing and should avoid eating or drinking for at least one hour post-use to minimize the risk of choking. Immediate medical attention is warranted if excessive numbness, breathing difficulties, dizziness, or bluish skin is observed.

Parents or caregivers should discontinue use and consult a healthcare professional if the child experiences severe burning, swelling, irritation, rash, or prolonged numbing lasting more than 1-2 hours. Prior to use, it is advisable to consult a doctor if the pediatric patient has respiratory, heart, or liver conditions, is pregnant or breastfeeding, or is taking any medications that may interact with this product.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication, particularly if they have respiratory, heart, or liver issues. The safety of this medication during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to discuss their individual circumstances and any interacting medications with their healthcare provider prior to use.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication if they have respiratory, heart, or liver issues, are pregnant or breastfeeding, or are taking any interacting medications. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to use, particularly if they have any respiratory, cardiac, or liver issues. It is essential for patients to disclose their liver function status, as this may influence the safety and efficacy of the treatment. Additionally, patients who are pregnant, breastfeeding, or taking medications that may interact with the treatment should also seek medical advice before use. Monitoring of liver function may be warranted in patients with compromised liver function to ensure appropriate management and to mitigate potential risks associated with the treatment.

Overdosage

Overdosage of the medication may lead to an increased risk of methemoglobinemia, a condition characterized by elevated levels of methemoglobin in the blood, which can impair the oxygen-carrying capacity of hemoglobin.

In the event of suspected overdosage, it is imperative to contact Poison Control at 1-800-222-1222 for immediate guidance. Healthcare professionals should be prepared to provide information regarding the amount ingested and the time of exposure to facilitate appropriate management.

Nonclinical Toxicology

No teratogenic effects were observed in animal studies, and there was no increase in fetal malformations noted. However, studies in animals have demonstrated that benzocaine can induce methemoglobinemia, particularly with high doses or prolonged exposure. Additionally, benzocaine has been associated with adverse developmental outcomes in animal studies at doses significantly higher than those used clinically.

Postmarketing Experience

Postmarketing experience has identified that overuse of the product may increase the risk of methemoglobinemia. This information is based on reports received voluntarily and through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of a suspected overdose or accidental exposure, patients should be instructed to contact Poison Control immediately for guidance and assistance.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. Currently, there are no specific storage or handling instructions provided in the SPL text. Therefore, standard storage practices should be followed to ensure the integrity of the product. It is advisable to store the product in a controlled environment, away from direct sunlight and extreme temperatures, to maintain its quality.

Additional Clinical Information

Patients should be advised on the proper administration of the medication, which involves using 1-2 sprays to the throat for adults aged 18 and older, with a maximum of 3-4 sprays per use. It is recommended to allow 30-60 seconds before swallowing and to wait 1-2 minutes for the full effect, as the numbing sensation typically fades within one hour. The maximum allowable dosage is 4 sprays per session and 12 sprays within a 24-hour period.

Clinicians should counsel patients to keep the product out of reach of children and to contact Poison Control in the event of accidental ingestion. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Bvibe Spearmint Deep Throat, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Bvibe Spearmint Deep Throat, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.